‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
The Beacon
Atezolizumab in First Line NSCLC: Early Clinical Results from the IMpower150 Trial (BMIC-020)
30
00:00:00
/ 00:11:28
30